NCT01773668View on ClinicalTrials.gov

Feasibility Study - Integrated Sensor and Infusion Set. Trial III

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
DEVICE

Integrated sensor and infusion set.

Trial Locations (1)

205 02

Skåne University Hospital, Department of Endokrinology, Malmo

All Listed Sponsors
lead

Medtronic Diabetes R&D Denmark

INDUSTRY

NCT01773668 - Feasibility Study - Integrated Sensor and Infusion Set. Trial III | Biotech Hunter | Biotech Hunter